[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100598720":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":31,"locations":37,"responsibleParty":53,"collaborators":18,"id":56,"slug":18,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":18,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":18,"overallStatus":39,"whyStopped":18,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"University of Kentucky","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Wound Dressing","EXPERIMENTAL","At the conclusion of the surgical procedure, patients will receive topical wound dressing to surgical sutured periocular wounds",[13],"Device: Hydrocolloid Wound Dressing",{"label":15,"type":16,"description":17,"interventionNames":18},"Antibiotic Ointment (Control)","NO_INTERVENTION","At the conclusion of the surgical procedure, patients will receive topical antibiotic ophthalmic ointment to surgical sutured periocular wounds",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","Hydrocolloid Wound Dressing","one time hydrocolloid dressing application",[9],[26],"DuoDERM Extra Thin dressing",[28],{"name":29,"affiliation":5,"role":30},"Janice Hernandez, MD","PRINCIPAL_INVESTIGATOR",[32],{"name":33,"role":34,"phone":35,"phoneExt":18,"email":36},"Connie Dampier","CONTACT","859-562-0750","dampier@uky.edu",[38],{"facility":5,"status":39,"city":40,"state":41,"zip":42,"country":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","Lexington","Kentucky","40508","United States",{"type":45,"coordinates":46},"Point",[47,48],-84.47772,37.98869,{"lat":48,"lon":47},[51],{"name":52,"role":30,"phone":18,"phoneExt":18,"email":18},"Janice Hernandez, M.D.",{"type":54,"investigatorFullName":29,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"SPONSOR_INVESTIGATOR","Instructor","100598720",false,"NCT07075159","Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing","HCD Wound Heal","Inclusion Criteria:\n\n* Patients \\>18 years of age\n* follow-up at specified intervals (1 week\u002F6 week\u002F3 months) in an office setting\n* can give informed consent\n* no patients will be excluded on the basis of gender, ethnicity, or religious background\n\nExclusion Criteria:\n\n* Patients \\\u003C18 years of age or \\>100\n* allergy to pectin, gelatin, and sodium carboxymethylcellulose\n* adults with impaired consent capacity\n* incarcerated individuals.","ALL","18 Years","100 Years",{"count":66,"type":67},20,"ESTIMATED","INTERVENTIONAL",[70],"NA","This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointment application and reduce the burden of post-operative care on the patient.",[73,74,75],"Wound Healing","Mohs Micrographic Surgery","Oculofacial Reconstruction","2025-12-15",{"date":78,"type":79},"2025-12-17","ACTUAL",{"date":81,"type":79},"2025-02-28",{"date":83,"type":67},"2026-09-01",{"name":29,"class":6},1]